Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Virology|July 22, 2022
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus VariantsThandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N Mkhize, et al.
Clinical Immunology (Orlando, Fla.)|December 23, 2023
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell responseClaire Butters, Ntombi Benede, Thandeka Moyo-Gwete, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Plos Pathogens|November 9, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodiesThandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
Cell Reports. Medicine|April 27, 2022
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernDale Kitchin, Simone I Richardson, Mieke A van der Mescht, et al.
Cell Host & Microbe|April 18, 2022
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individualsSimone I Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Nature Communications|March 16, 2024
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiationFarina Karim, Catherine Riou, Mallory Bernstein, et al.
Cell Host & Microbe|October 24, 2021
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent mannerRoanne Keeton, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Pageof 3